THE DEAL, AT A GLANCE
From the announcementNura Bio Completes 738m
01Who is involvedBacked by The Column Group, Euclidean Capital, Samsara BioCapital, Sanofi VenturesFrom the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗02What happenedNura Bio Completes 738m raised $73.8M Series B, announced 2026-06-22From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗03Why it mattersNura Bio's Series B supports a clinical-stage neurotherapeutics program focused on neuroprotective small-molecule SARM1 inhibitors for axon degeneration, with ALS as the…From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗
Nura Bio Completes 738m · Financing Record
Explore source-linked visual explanations for Nura Bio Completes 738m. Unsupported claims are withheld while source review continues.
Record 10466 · Recorded date: 2026-06-22
Explore company records →